Ignite Creation Date:
2025-12-24 @ 3:28 PM
Ignite Modification Date:
2026-02-22 @ 7:23 AM
Study NCT ID:
NCT00121992
Status:
COMPLETED
Last Update Posted:
2023-04-04
First Post:
2005-07-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment
Sponsor:
Spanish Breast Cancer Research Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GEICAM 9805
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |